Advanced Biomedical Research

Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians

Authors

1 Department of Tata Proteomics and Coagulation; Elizabeth and Emmanuel Kaye Bioinformatics and Biostatistics Department, Thrombosis Research Institute, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India

2 Elizabeth and Emmanuel Kaye Bioinformatics and Biostatistics Department, Thrombosis Research Institute, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India

3 Department of Tata Proteomics and Coagulation, Thrombosis Research Institute, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India

Abstract

Background: Multi-marker approaches for risk prediction in coronary artery disease (CAD) have been inconsistent due to biased selection of specific know biomarkers. We have assessed the global proteome of CAD-affected and unaffected subjects, and developed a pathway network model for elucidating the mechanism and risk prediction for CAD.
Materials and Methods: A total of 252 samples (112 CAD-affected without family history and 140 true controls) were analyzed by Surface-Enhanced Laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS) by using CM10 cationic chips and bioinformatics tools.
Results: Out of 36 significant peaks in SELDI-TOF MS, nine peaks could do better discrimination of CAD subjects and controls (area under the curve (AUC) of 0.963) based on the Support Vector Machine (SVM) feature selection method. Of the nine peaks used in the model for discrimination of CAD-affected and unaffected, the m/z corresponding to 22,859 was identified as stress-related protein HSP27 and was shown to be highly associated with CAD (odds ratio of 3.47). The 36 biomarker peaks were identified and a network profile was constructed showing the functional association between different pathways in CAD.
Conclusion: Based on our data, proteome profiling with SELDI-TOF MS and SVM feature selection methods can be used for novel network biomarker discovery and risk stratification in CAD. The functional associations of the identified novel biomarkers suggest that they play an important role in the development of disease.

Keywords

1. Martin-Ventura JL, Blanco-Colio LM, Tuñón J, Muñoz-García B, Madrigal-Matute J, Moreno JA, et al. Biomarkers in cardiovascular medicine. Rev Esp Cardiol 2009;62:677-88.  Back to cited text no. 1
    
2. Kanjilal S, Rao VS, Mukherjee M, Natesha BK, Renuka KS, Sibi K, et al. Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians. Vasc Health Risk Manag 2008;4:199-211.  Back to cited text no. 2
[PUBMED]    
3. Kim HC, Greenland P, Rossouw JE, Manson JE, Cochrane BB, Lasser NL, et al. Multimarker prediction of coronary heart diasease risk: The Women's Health Initiative. J Am Coll Cardiol 2010;55:2080-91.  Back to cited text no. 3
[PUBMED]    
4. Rao VS, Kadarinarasimhiah NB, John S, Hebbagodi S, Shanker J, Kakkar VV. Usefulness of C-reactive protein as a marker for prediction of future coronary events in the Asian Indian population: Indian atherosclerosis research study. Int J Vasc Med 2010;2010:389235.  Back to cited text no. 4
[PUBMED]    
5. Shanker J, Perumal G, Maitra A, Rao VS, Natesha BK, John S, et al. Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease. J Genet 2009;88:291-7.  Back to cited text no. 5
[PUBMED]    
6. Wang Y, Hu X, Wang JA, Xiang M, Yu J, Liu F, et al. Application of serum protein fingerprint in diagonisis of coronary artery disease. Clin Biochem 2011;44:185-91.  Back to cited text no. 6
[PUBMED]    
7. Edwards AV, White MY, Cordwell SJ. The role of proteomics in clinical cardiovascular biomarker discovery. Moll Cell Proteomics 2008;7:1824-37.  Back to cited text no. 7
    
8. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification. Biochem Biophys Res Commun 2002;292:587-92.  Back to cited text no. 8
[PUBMED]    
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.  Back to cited text no. 9
[PUBMED]    
10. Jin G, Zhou X, Wang H, Zhao H, Cui K, Zhang XS, et al. The knowledge-integrated network biomarkers discovery for major adverse cardiac events. J Proteome Res 2008;7:4013-21.  Back to cited text no. 10
[PUBMED]    
11. Chen YD, Zheng S, Yu JK, Hu X. Artificial neural networks analysis of surface enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 2004;10:8380-5.  Back to cited text no. 11
[PUBMED]    
12. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein identification and analysis tools on the ExPASY server. In: Walker JM, editor. The Proteomics Protocols Handbook.Humana Press Inc (Springer Protocols). New York, USA; 2005. p. 571-607.  Back to cited text no. 12
    
13. Wilkins MR, Gasteiger E, Sanchez JC, Appel RD, Hochstrasser DF. Protein identification with sequence tags. Curr Biol 1996;6:1543-4.  Back to cited text no. 13
[PUBMED]    
14. Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, et al. Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol 1998;278:599-608.  Back to cited text no. 14
[PUBMED]    
15. Lomthaisong K, Bonmaleerat K, Wingpia A. Proteomic study of recombinant Escherichia coli expressing Beauveria bassiana chitinase gene. Chiang Mai J Sci 2008;35:324-30.  Back to cited text no. 15
    
16. Szklarczyk D, Franceschini A, Khun M, Simonovic M, Roth A, Minquez P, et al. The STRING database in 2011: Functional interaction networks of proteins globally integrated and scored. Nucleic Acid Res 2011;39:D561-8.  Back to cited text no. 16
    
17. Baggerly KA, Morris HS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 2004;20:777-85.  Back to cited text no. 17
    
18. Willian SN. What is support vector machine? Nat Biotechnol 2006;24:1565-7.  Back to cited text no. 18
    
19. Son YJ, Kim HG, Kim EH, Choi S, Lee SK. Applications of support vector machine for prediction of medication adherence in heart failure patients. Healthc Inform Res 2010;16:253-9.  Back to cited text no. 19
[PUBMED]    
20. Yu JK, Zheng S, Tang Y, Li L. An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer. J Zhejiang Univ Sci B 2005;6:227-31.  Back to cited text no. 20
    
21. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is athreosclerosis an immunologically mediated disease? Immunol Today 1995;16:27-33.  Back to cited text no. 21
[PUBMED]    
22. Ghayour-Mobarhan M, Rahsepar AA, Tavaillaie S, Rahsepar S, Ferns GA. The potential role of heat shock proteins in cardiovascular disease: Evidence from in vitro and in vivo studies. Adv Clin Chem 2009;48:27-72.  Back to cited text no. 22
    
23. Wick G. The geat is on: Heat shock proteins and atherosclerosis. Circulation 2006;114:870-2.  Back to cited text no. 23
[PUBMED]    
24. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerosis plaques. J Clin Invest 1994;94:2493-503.  Back to cited text no. 24
[PUBMED]    
25. Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodelling. Thromb Haemost 2001;86:324-33.  Back to cited text no. 25
[PUBMED]    
26. Martin-Ventura JL, Duran MC, Blanco-Colio LM, Meilhac O, Leclercq A, Michel JB, et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004;110:2216-9.  Back to cited text no. 26
[PUBMED]    
27. Hollander JM, Martin JL, Belke DD, Scott BT, Swanson E, Krishnamoorthy V, et al. Overexpression of wild-type heat shock protein 27 and a nonphosphprylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 2004;110:3544-52.  Back to cited text no. 27
[PUBMED]    
Advanced Biomedical Research
Volume 2013, July
July 2013
Pages 1-10